• Nektar Therapeutics (NASDAQ:NKTR) Receives Average Recommendation of "Moderate Buy" from Brokerages

    المصدر: Buzz FX / 14 يناير 2025 04:56:16   America/New_York


    Nektar Therapeutics (NASDAQ:NKTR) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) has been assign
    Read more...
شارك على،